Back to the full story6 sources · Revolution Medicines gets FDA nod for targeted pancreatic cancer drug◆ Analytics
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
Deterministic text analytics computed across all 6 sources. Frequency, entity overlap, and claim overlap — computed counts only. Nothing is rated true or false.
01
Frequency Analytics
The most common words and exact phrases across every report in this cluster. Computed counts only.
Top words
cancerpancreaticdrugapprovedrevolutionmedicinestreatmenttargetedapprovesadministration
Top phrases
pancreatic cancerpancreatic cancer drugcancer drugrevolution medicines
02
Entity Overlap
Names detected in the report text: which appear across multiple sources, and which only one source mentions.
Across multiple sources
- Drug Administration · 2 sources
- FDA · 2 sources
- Food · 2 sources
- Revolution Medicines · 2 sources
Unique to one source
- Philly · Northeast Times
- STAT · STAT
- Pharmalittle · STAT
- We’re · STAT
- Companies · The New York Times — Business
- Ben Sasse · WOWT
- Omaha · WOWT
- Pancreatic · Scientific American
03
Claim Overlap
Near-identical sentences found in two or more reports, versus sentences that appear in only one. Text match only — nothing is rated true or false.
Repeated across sources
No sentence appeared in more than one source.
Appears once
- "Food and Drug Administration on Wednesday approved Revolution Medicines' targeted drug for adults with metastatic pancreatic cancer who have received prior treatment or cannot receive combination chemotherapy." · KSL
- "The FDA approved a life-extending treatment for advanced pancreatic cancer from Revolution Medicines that is the first to attack a genetic cause Good morning, everyone, and how are you today?" · STAT
- "We are doing just fine, thank you, despite the soggy weather hovering over the Pharmalot campus right now, because our spirits remain sunny, nonetheless." · STAT
- "Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more." · The New York Times — Business
- "Pancreatic cancer is considered one of the hardest to treat and most serious forms of cancer Pancreatic cancer is considered one of the hardest to treat and most serious forms of cancer" · Scientific American